![Efficacy and safety of once daily elvitegravir versus twice daily raltegravir in treatment-experienced patients with HIV-1 receiving a ritonavir-boosted protease inhibitor: randomised, double-blind, phase 3, non-inferiority study - The Lancet ... Efficacy and safety of once daily elvitegravir versus twice daily raltegravir in treatment-experienced patients with HIV-1 receiving a ritonavir-boosted protease inhibitor: randomised, double-blind, phase 3, non-inferiority study - The Lancet ...](https://www.thelancet.com/cms/attachment/2119434865/2093775053/gr1.gif)
Efficacy and safety of once daily elvitegravir versus twice daily raltegravir in treatment-experienced patients with HIV-1 receiving a ritonavir-boosted protease inhibitor: randomised, double-blind, phase 3, non-inferiority study - The Lancet ...
![Intrinsic transcriptomic sex differences in human endothelial cells at birth and in adults are associated with coronary artery disease targets | Scientific Reports Intrinsic transcriptomic sex differences in human endothelial cells at birth and in adults are associated with coronary artery disease targets | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-69451-8/MediaObjects/41598_2020_69451_Fig1_HTML.png)
Intrinsic transcriptomic sex differences in human endothelial cells at birth and in adults are associated with coronary artery disease targets | Scientific Reports
![High-stakes crisis management in the Low Countries: Comparing government responses to COVID-19 - Valérie Pattyn, Joery Matthys, Steven Van Hecke, 2021 High-stakes crisis management in the Low Countries: Comparing government responses to COVID-19 - Valérie Pattyn, Joery Matthys, Steven Van Hecke, 2021](https://journals.sagepub.com/cms/10.1177/0020852320972472/asset/images/large/10.1177_0020852320972472-fig1.jpeg)
High-stakes crisis management in the Low Countries: Comparing government responses to COVID-19 - Valérie Pattyn, Joery Matthys, Steven Van Hecke, 2021
![Bortezomib, thalidomide, and dexamethasone with or without daratumumab for transplantation-eligible patients with newly diagnosed multiple myeloma (CASSIOPEIA): health-related quality of life outcomes of a randomised, open-label, phase 3 trial - The Lancet Bortezomib, thalidomide, and dexamethasone with or without daratumumab for transplantation-eligible patients with newly diagnosed multiple myeloma (CASSIOPEIA): health-related quality of life outcomes of a randomised, open-label, phase 3 trial - The Lancet](https://www.thelancet.com/cms/asset/7505e105-5780-415f-b63f-5bf25207d553/gr1.jpg)
Bortezomib, thalidomide, and dexamethasone with or without daratumumab for transplantation-eligible patients with newly diagnosed multiple myeloma (CASSIOPEIA): health-related quality of life outcomes of a randomised, open-label, phase 3 trial - The Lancet
![Late-Breaking Science Abstracts and Featured Science Abstracts From the American Heart Association's Scientific Sessions 2022 and Late-Breaking Abstracts in Resuscitation Science From the Resuscitation Science Symposium 2022 | Circulation Late-Breaking Science Abstracts and Featured Science Abstracts From the American Heart Association's Scientific Sessions 2022 and Late-Breaking Abstracts in Resuscitation Science From the Resuscitation Science Symposium 2022 | Circulation](https://www.ahajournals.org/cms/asset/5d322c62-6477-4f12-9906-1da3b42f815f/cir.0000000000001116.fig12.jpg)
Late-Breaking Science Abstracts and Featured Science Abstracts From the American Heart Association's Scientific Sessions 2022 and Late-Breaking Abstracts in Resuscitation Science From the Resuscitation Science Symposium 2022 | Circulation
![Abstracts from ATTD 2017 10th International Conference on Advanced Technologies & Treatments for Diabetes Paris, France—February 15–18, 2017 | Diabetes Technology & Therapeutics Abstracts from ATTD 2017 10th International Conference on Advanced Technologies & Treatments for Diabetes Paris, France—February 15–18, 2017 | Diabetes Technology & Therapeutics](https://www.liebertpub.com/cms/10.1089/dia.2017.2525.abstracts/asset/images/medium/figure14.gif)
Abstracts from ATTD 2017 10th International Conference on Advanced Technologies & Treatments for Diabetes Paris, France—February 15–18, 2017 | Diabetes Technology & Therapeutics
![Events and webinars - FIP - International Pharmaceutical Federation Announcements of pharmacy and pharmaceutical science and pharmacy education events, meetings and workshops around the world. Events and webinars - FIP - International Pharmaceutical Federation Announcements of pharmacy and pharmaceutical science and pharmacy education events, meetings and workshops around the world.](https://www.fip.org/files/content/events/2023/2906_web.jpg)
Events and webinars - FIP - International Pharmaceutical Federation Announcements of pharmacy and pharmaceutical science and pharmacy education events, meetings and workshops around the world.
![JCM | Free Full-Text | The COVID-19 Pandemic and Dental Professionals’ Infection Risk Perception: An International Survey JCM | Free Full-Text | The COVID-19 Pandemic and Dental Professionals’ Infection Risk Perception: An International Survey](https://pub.mdpi-res.com/jcm/jcm-12-06762/article_deploy/html/images/jcm-12-06762-g001-550.jpg?1698311852)
JCM | Free Full-Text | The COVID-19 Pandemic and Dental Professionals’ Infection Risk Perception: An International Survey
![Dynamics of non-household contacts during the COVID-19 pandemic in 2020 and 2021 in the Netherlands | Scientific Reports Dynamics of non-household contacts during the COVID-19 pandemic in 2020 and 2021 in the Netherlands | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-023-32031-7/MediaObjects/41598_2023_32031_Fig1_HTML.png)
Dynamics of non-household contacts during the COVID-19 pandemic in 2020 and 2021 in the Netherlands | Scientific Reports
![Events and webinars - FIP - International Pharmaceutical Federation Announcements of pharmacy and pharmaceutical science and pharmacy education events, meetings and workshops around the world. Events and webinars - FIP - International Pharmaceutical Federation Announcements of pharmacy and pharmaceutical science and pharmacy education events, meetings and workshops around the world.](https://www.fip.org/files/content/events/2023/2211_WEB.jpg)